EichorEICHOR
Location: Riverside Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Riverside

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Kaiser Permanente Riverside Medical Center · Joseph Broderick, MD · NCT07227246A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Clinical Innovations, Inc. dba CITrials · Bristol-Myers Squibb · NCT06929273Digital Health Intervention for Children With ADHD
NA · UCR Psychiatry at Grindstaff Community School · University of California, Riverside · NCT06456372A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Artemis Institute for Clinical Research · Kallyope Inc. · NCT07674654Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Alliance for Clinical Trials in Oncology · NCT07321652Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Eli Lilly and Company · NCT06890598A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Artemis Institute for Clinical Research · Eli Lilly and Company · NCT07369011Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · NRG Oncology · NCT05946213Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149Nectero EAST System Clinical Study
Phase 2/Phase 3 · Nectero Medical, Inc. · NCT06001918A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · Artemis Institute for Clinical Research · Eli Lilly and Company · NCT05986292Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-Riverside · NRG Oncology · NCT05174169Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Kaiser Permanente-Riverside · National Cancer Institute (NCI) · NCT04269902Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Kaiser Permanente-Riverside · Canadian Cancer Trials Group · NCT06592924Prevail Global Study
NA · Medtronic Vascular · NCT06535854Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
NA · EnCompass Technologies, Inc. · NCT06689839E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente-Riverside · NRG Oncology · NCT06748222Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
NA · Loma Linda University ENT/Head & Neck Surgery · Loma Linda University · NCT05575401Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Alliance for Clinical Trials in Oncology · NCT04242095Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Kaiser Permanente-Riverside · National Cancer Institute (NCI) · NCT05256225Effectiveness of Cognitive Training in Older and Younger Adults
NA · University of California, Riverside · University of Wisconsin, Madison · NCT06375681Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Phase 3 · Clinical Innovations, Inc. · LB Pharmaceuticals Inc. · NCT07363577A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
Phase 2 · Zenas BioPharma (USA), LLC · NCT06559163Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · Eastern Cooperative Oncology Group · NCT05108298ViewFlex X ICE First-in-Human Study
Phase N/A · Abbott Medical Devices · NCT06772493A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · Clinical Innovations, Inc. dba CITrials · Bristol-Myers Squibb · NCT07140913Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · ECOG-ACRIN Cancer Research Group · NCT04566328De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Kaiser Permanente-Riverside · NRG Oncology · NCT04852887Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Phase 3 · Reviva site · Reviva Pharmaceuticals · NCT05184335
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.